Population (July 2006 estimate)
107.4m
GDP (2005 - PPP basis)
$1.08trn
Health expenditure (2004)
Health expenditure as proportion of GDP (2004)
Size of pharmaceutical market (2005 estimate)
Percentage of health expenditure spent on pharmaceuticals (2002)
Proportion of GDP spent on pharmaceuticals (2004)
Pharmaceutical market growth rate
Local currency
Mexican Peso (MXN)
Summary: Mexico
Mexico is undergoing significant healthcare reforms. Direct state intervention in pharmaceutical pricing is a feature that sets Mexico apart from some other Latin American countries. Nevertheless, since 1996, these measures have been somewhat relaxed.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
There are no news items for this country.
View all articles for Latin America »
Related Items